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1. Introduction
Renal diseases are notoriously silent. Renal diseases are notoriously expensive
once they have led to end-stage renal failure requiring dialysis or transplantation.
Most acute and chronic renal diseases present with rising serum creatinine and
blood urea nitrogen, electrolyte abnormalities, frequent proteinuria, occasional red
blood cells in the urine, occasional white blood cells in the urine, or renal cells in the
urine often mistaken for white blood cells. It is not easy to make a specific diagnosis
from these similar presentations.
I will now present the rationale for renal biopsy to establish renal diagnoses [1].
The classification which follows is the opinion of the author and editor based on
over 45 years of experience and exposure to the pioneers in use of renal biopsy for
diagnosis [2–4]. My goal is to simplify this argument for performing this invasive
procedure to clarify the confusing array of renal diseases with indistinct or asymp-
tomatic presentations.
2. Renal disease diagnosis
Acute renal diseases are described as prerenal, renal, and postrenal, but most
patients totally recover normal or near-normal renal function. It is the chronic,
often symptomless chronic diseases which lead surreptitiously to end-stage renal
disease. Chronic diseases include vascular, glomerular, tubular, and interstitial dis-
eases. The main structures of the kidney are arteries and veins, glomeruli, tubules,
and interstitium. Renal biopsy is often required to determine the site of injury. As
described below, even when the site of injury is known, such as in glomerular
diseases, the renal biopsy is needed to distinguish between the many similar dis-
eases in order to develop possible remission-inducing therapy strategies.
I have been teaching about renal diseases since for 40 years since 1979. I have
been struck by three main perspectives. First, diseases can occur in very small areas
of the structures of the kidney while the rest of the kidney tissues work well and try
to compensate. Second, glomerular diseases are confusing to understand because
one needs a framework to separate the multiple very similar diseases into separate
clinically relevant entities allowing individual management. Finally, the tubular
diseases are the most silent of renal diseases, needing more effort to teach, under-
stand, identify, and manage. Renal biopsy results will be briefly described as the
tool to make a definitive diagnosis necessary for proper patient management.
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3. Renal biopsy
Normal renal histology must be known to the clinician before biopsy can be
interpreted. The glomeruli will be numerous and have wide-open, thin-walled
capillary loops; no inflammatory cells seen; and no increase in numbers of
mesangial cells. There can be less than 30% of any glomerulus or all glomeruli which
contain amorphous loss of architecture called sclerosis. The blood vessels need to be
open without cellular or muscular thickening. Finally, the cross section of renal
tubules normally abuts directly against each other without evidence of inflamma-
tory cells or scarring by fibrosis between them.
4. Renal diseases identified by biopsy
Glomerular diseases require the visualization of light microscopy to best under-
stand the numerous entities, many of which have similar immune-mediated patho-
physiology. There are nine main light microscopic patterns. Each has a primary and
secondary form. This classification allows one to understand the differences of 18
different confusing entities. These patterns are nil lesion, diffuse membranous,
diffuse proliferative, diffuse membranoproliferative, focal proliferative, focal scle-
rosis, nodular glomerulosclerosis, fibrillary, and amyloidosis. For almost everyone,
there is a primary and secondary form. The primary forms are idiopathic. The
secondary forms are due to a bacteria or virus, a drug, or a systemic disease such as
lupus. Based on the light microscopy, the clinician determines if there is a definite
cause or whether it is primary. From either category a specific management has
reached consensus by nephrologists through international symposia and guidelines.
Tubular diseases do not often show azotemia early. Rather subtle electrolyte
findings such as hyperkalemia, hyperuricemia, or non-anion gap metabolic acidosis
suggest this category of disease. However, since those disturbances can occur with
nonrenal diseases such as gastrointestinal problems, they are not often recognized
as early signs of renal damage. Renal biopsy helps distinguish the following most
common causes: obstructive or reflux nephropathy, hypertensive injury called acute
or chronic nephrosclerosis, drug-induced diseases such as due to analgesics, heavy
metal injury such as due to lead, crystal diseases such as urate or oxalate, and
unknown causes such as Balkan or other environmental nephritides.
Vascular diseases may occur with or without glomerulonephritis. Fibrinoid
necrosis, chronic hypertensive changes of the arteries (nephrosclerosis), and vas-
culitis are the most common patterns. Fibrinoid necrosis is seen with malignant
hypertension, thrombotic thrombocytopenic purpura, scleroderma, eclampsia, and
disseminated intravascular coagulation.
Interstitial diseases are identified by acute and chronic inflammatory cells or
fibroblasts and collagenous scarring between the tubules causing secondary tubular
injury and renal failure. Chronic allograft nephropathy and chronic pyelonephritis
are two examples.
5. Conclusion
The above framework to be used for the management of patients with chronic
unexplained or understood renal insufficiency is frequently changing. New entities
are appearing to add more patterns, more secondary causes of glomerular diseases,
and new algorithms for management [5, 6]. Renal disease due to human
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immunodeficiency virus, new drugs including new biologicals, and new immuno-
logic diseases accounts for some of these newer entities.
In conclusion, a word should be said about repeat renal biopsies. Repeat biopsies
are encouraged to assess response to treatment such as in allograft rejection. Repeat
biopsies are used to reassess those diseases such as lupus nephritis which can change
course leading to new pathophysiology and demanding a change in therapeutic
strategy.
Finally, the group at New York Presbyterian/Columbia University Medical
Center should be commended as they have continued to provide the most compre-
hensive annual tutorial and update of the interpretation of renal biopsies based on
the very large number of biopsies referred to them [7]. Many of the chapters in this
book concentrate on the importance of renal biopsy for diagnosis. Other chapters
deal with methods of performing renal biopsy. Finally, there are chapters dealing
with complications of renal biopsy.
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